Cargando…

Meta‑analysis of the efficacy and safety of nifekalant in the conversion of atrial fibrillation

Atrial fibrillation (AF) is the most common type of supraventricular tachyarrhythmia. Nifekalant is a new class III antiarrhythmic drug approved for the treatment of ventricular tachyarrhythmias, but its effectiveness in converting AF to sinus rhythm remains unclear. The present analysis aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Li, Kaiyuan, Wang, Shuya, Liu, Miao, Wang, Lei, Su, Guohai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780521/ https://www.ncbi.nlm.nih.gov/pubmed/36588807 http://dx.doi.org/10.3892/etm.2022.11755

Ejemplares similares

Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings
por: Hu, Jinzhu, et al.
Publicado: (2019)

Atrial pacing and administration of nifekalant hydrochloride for unstable atrial fibrillation: a case report
por: Yakabe, Daisuke, et al.
Publicado: (2020)

Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia
por: Sato, Shiho, et al.
Publicado: (2017)

Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
por: Yang, Liu, et al.
Publicado: (2020)

Effect of nifekalant for out-of–hospital cardiac arrest with shock-resistant ventricular fibrillation
por: Toyama, H, et al.
Publicado: (2004)

Comparison of nifekalant and amiodarone for resuscitation after cardiopulmonary arrest due to shock-resistant ventricular fibrillation
por: Harayama, N, et al.
Publicado: (2011)

The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis
por: Jiang, Yun-Qiu, et al.
Publicado: (2018)

Meta-analysis of effect of vernakalant on conversion of atrial fibrillation
por: Yan, He, et al.
Publicado: (2013)

Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation
por: Harayama, Nobuya, et al.
Publicado: (2014)

Efficacy and Safety of Ablation for Symptomatic Atrial Fibrillation in Elderly Patients: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis
por: Tng, Eng-Loon, et al.
Publicado: (2022)

Nifekalant unmasked residual gap of superior vena cava isolation by suppressing immediate recurrence of intra‐superior vena cava fibrillation
por: Sekihara, Takayuki, et al.
Publicado: (2022)

Acute atrial wall stretch and the efficacy of flecainide-induced conversion of atrial fibrillation
por: van Hemel, N.M., et al.
Publicado: (2015)

Relative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation by network meta-analysis
por: Fu, Wenbin, et al.
Publicado: (2014)

Comparison of the Efficacy and Safety Endpoints of Five Therapies for Atrial Fibrillation: A Network Meta-Analysis
por: Wang, Tongyu, et al.
Publicado: (2022)

Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Wang, Yapeng, et al.
Publicado: (2023)

A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation
por: Wei, Zhonghai, et al.
Publicado: (2016)

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
por: Vallakati, Ajay, et al.
Publicado: (2016)

Efficacy and safety of thrombolysis for acute ischemic stroke with atrial fibrillation: a meta-analysis
por: Hu, Yunzhen, et al.
Publicado: (2021)

Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction
por: Liu, Peng, et al.
Publicado: (2023)

Safety and efficacy of ablation for atrial fibrillation in combination with left atrial appendage occlusion in octogenarians
por: Zhang, Peng‐Pai, et al.
Publicado: (2023)

Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia
por: Xiao, Hongyan, et al.
Publicado: (2022)

Stellate ganglion blockade combined with nifekalant for patients with electrical storm: a case report
por: Kiyohara, Takuya, et al.
Publicado: (2022)

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis
por: Zhou, Qiang, et al.
Publicado: (2023)

Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation
por: Martin, Andrew, et al.
Publicado: (2012)

A systematic review and meta-analysis of the safety and efficacy of left atrial substrate modification in atrial fibrillation patients with low voltage areas
por: Mao, Shaobin, et al.
Publicado: (2022)

Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
por: Nochaiwong, Surapon, et al.
Publicado: (2016)

Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: a network meta-analysis
por: Charitakis, Emmanouil, et al.
Publicado: (2022)

Efficacy and Safety of Catheter Ablation Combined with Left Atrial Appendage Closure in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Wang, An, et al.
Publicado: (2022)

Anesthetic management of a patient with severe aortic regurgitation undergoing reoperation for ascending aorta false aneurysm using hypothermia: prevention of ventricular fibrillation by nifekalant
por: Tomita, Akiko, et al.
Publicado: (2021)

Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)

Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation: A protocol for systematic review and meta-analysis
por: Li, Hong, et al.
Publicado: (2022)

Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation
por: Liu, Chaofan, et al.
Publicado: (2023)

Nifekalant versus Amiodarone for Out-Of-Hospital Cardiac Arrest with Refractory Shockable Rhythms; a Post Hoc Analysis
por: Funakoshi, Hiraku, et al.
Publicado: (2022)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis
por: Xiong, Qinmei, et al.
Publicado: (2019)

Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
por: Beatch, Gregory N., et al.
Publicado: (2016)

Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis
por: Guo, Wenqin, et al.
Publicado: (2020)

Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation
por: Xu, Yaning, et al.
Publicado: (2023)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_43a7lhlrhhtkcg7tmrvpqfdplg